Published in Vaccine Weekly, September 13th, 1999
The strategy, dubbed Serologic Testing Algorithm for determining Recent HIV Seroconversion (STARHS), is the creation of the U.S. Centers for Disease Control and Prevention (CDC). It distinguishes people who have acquired HIV infections in the past four to six months from those with more longstanding infections.
Helene Gayle, director of the CDC's National Center for HIV, STD, and TB, announced the strategy in a press conference at the National HIV Prevention Conference, held August 29-September 1, 1999, in Atlanta, Georgia.
"STARHS is one of many new...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly